Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


A family of anti-Bacteroidales peptide toxins wide-spread in the human gut microbiota.

Coyne MJ, B├ęchon N, Matano LM, McEneany VL, Chatzidaki-Livanis M, Comstock LE.

Nat Commun. 2019 Aug 1;10(1):3460. doi: 10.1038/s41467-019-11494-1.


Acquisition of MACPF domain-encoding genes is the main contributor to LPS glycan diversity in gut Bacteroides species.

McEneany VL, Coyne MJ, Chatzidaki-Livanis M, Comstock LE.

ISME J. 2018 Dec;12(12):2919-2928. doi: 10.1038/s41396-018-0244-4. Epub 2018 Jul 31.


Gut Symbiont Bacteroides fragilis Secretes a Eukaryotic-Like Ubiquitin Protein That Mediates Intraspecies Antagonism.

Chatzidaki-Livanis M, Coyne MJ, Roelofs KG, Gentyala RR, Caldwell JM, Comstock LE.

mBio. 2017 Nov 28;8(6). pii: e01902-17. doi: 10.1128/mBio.01902-17.


Bacteroidales Secreted Antimicrobial Proteins Target Surface Molecules Necessary for Gut Colonization and Mediate Competition In Vivo.

Roelofs KG, Coyne MJ, Gentyala RR, Chatzidaki-Livanis M, Comstock LE.

mBio. 2016 Aug 23;7(4). pii: e01055-16. doi: 10.1128/mBio.01055-16.


Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species.

Chatzidaki-Livanis M, Geva-Zatorsky N, Comstock LE.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3627-32. doi: 10.1073/pnas.1522510113. Epub 2016 Mar 7.


Friend turned foe: a role for bacterial sulfatases in colitis.

Chatzidaki-Livanis M, Comstock LE.

Cell Host Microbe. 2015 May 13;17(5):540-1. doi: 10.1016/j.chom.2015.04.012.


An antimicrobial protein of the gut symbiont Bacteroides fragilis with a MACPF domain of host immune proteins.

Chatzidaki-Livanis M, Coyne MJ, Comstock LE.

Mol Microbiol. 2014 Dec;94(6):1361-74. doi: 10.1111/mmi.12839. Epub 2014 Nov 14.


Phylum-wide general protein O-glycosylation system of the Bacteroidetes.

Coyne MJ, Fletcher CM, Chatzidaki-Livanis M, Posch G, Schaffer C, Comstock LE.

Mol Microbiol. 2013 May;88(4):772-83. doi: 10.1111/mmi.12220. Epub 2013 Apr 17.


Trans locus inhibitors limit concomitant polysaccharide synthesis in the human gut symbiont Bacteroides fragilis.

Chatzidaki-Livanis M, Weinacht KG, Comstock LE.

Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11976-80. doi: 10.1073/pnas.1005039107. Epub 2010 Jun 14.


A family of transcriptional antitermination factors necessary for synthesis of the capsular polysaccharides of Bacteroides fragilis.

Chatzidaki-Livanis M, Coyne MJ, Comstock LE.

J Bacteriol. 2009 Dec;191(23):7288-95. doi: 10.1128/JB.00500-09. Epub 2009 Oct 2.


A general O-glycosylation system important to the physiology of a major human intestinal symbiont.

Fletcher CM, Coyne MJ, Villa OF, Chatzidaki-Livanis M, Comstock LE.

Cell. 2009 Apr 17;137(2):321-31. doi: 10.1016/j.cell.2009.02.041.


Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis.

Coyne MJ, Chatzidaki-Livanis M, Paoletti LC, Comstock LE.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13099-104. doi: 10.1073/pnas.0804220105. Epub 2008 Aug 22.


Expression of a uniquely regulated extracellular polysaccharide confers a large-capsule phenotype to Bacteroides fragilis.

Chatzidaki-Livanis M, Coyne MJ, Roche-Hakansson H, Comstock LE.

J Bacteriol. 2008 Feb;190(3):1020-6. Epub 2007 Nov 26.


Bacteroides fragilis synthesizes a DNA invertase affecting both a local and a distant region.

Roche-Hakansson H, Chatzidaki-Livanis M, Coyne MJ, Comstock LE.

J Bacteriol. 2007 Mar;189(5):2119-24. Epub 2006 Dec 22.


Genetic distinctions among clinical and environmental strains of Vibrio vulnificus.

Chatzidaki-Livanis M, Hubbard MA, Gordon K, Harwood VJ, Wright AC.

Appl Environ Microbiol. 2006 Sep;72(9):6136-41.


Genetic variation in the Vibrio vulnificus group 1 capsular polysaccharide operon.

Chatzidaki-Livanis M, Jones MK, Wright AC.

J Bacteriol. 2006 Mar;188(5):1987-98.

Supplemental Content

Loading ...
Support Center